JP7653981B2 - 灌流血管造影を使用した腎除神経アブレーションのモニタリング - Google Patents
灌流血管造影を使用した腎除神経アブレーションのモニタリング Download PDFInfo
- Publication number
- JP7653981B2 JP7653981B2 JP2022521732A JP2022521732A JP7653981B2 JP 7653981 B2 JP7653981 B2 JP 7653981B2 JP 2022521732 A JP2022521732 A JP 2022521732A JP 2022521732 A JP2022521732 A JP 2022521732A JP 7653981 B2 JP7653981 B2 JP 7653981B2
- Authority
- JP
- Japan
- Prior art keywords
- state
- time series
- treatment
- diagnostic images
- region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000008660 renal denervation Effects 0.000 title claims description 56
- 238000002583 angiography Methods 0.000 title claims description 10
- 238000002679 ablation Methods 0.000 title description 43
- 230000010412 perfusion Effects 0.000 title description 24
- 238000012544 monitoring process Methods 0.000 title description 11
- 238000011282 treatment Methods 0.000 claims description 144
- 238000011298 ablation treatment Methods 0.000 claims description 119
- 238000000034 method Methods 0.000 claims description 73
- 239000002872 contrast media Substances 0.000 claims description 52
- 210000005166 vasculature Anatomy 0.000 claims description 33
- 239000003814 drug Substances 0.000 claims description 19
- 229940079593 drug Drugs 0.000 claims description 19
- 238000012545 processing Methods 0.000 claims description 19
- 238000004590 computer program Methods 0.000 claims description 9
- 238000010317 ablation therapy Methods 0.000 claims description 8
- 230000000638 stimulation Effects 0.000 claims description 7
- 230000001225 therapeutic effect Effects 0.000 claims description 4
- 238000002560 therapeutic procedure Methods 0.000 claims description 3
- 230000000007 visual effect Effects 0.000 claims description 3
- 210000002254 renal artery Anatomy 0.000 description 22
- 238000002203 pretreatment Methods 0.000 description 18
- 210000005036 nerve Anatomy 0.000 description 16
- 230000002889 sympathetic effect Effects 0.000 description 16
- 239000002160 alpha blocker Substances 0.000 description 15
- 230000000694 effects Effects 0.000 description 13
- 210000003734 kidney Anatomy 0.000 description 13
- 238000005259 measurement Methods 0.000 description 13
- 239000012530 fluid Substances 0.000 description 10
- 230000008569 process Effects 0.000 description 10
- 210000001367 artery Anatomy 0.000 description 9
- 230000036772 blood pressure Effects 0.000 description 9
- 206010020772 Hypertension Diseases 0.000 description 8
- 238000001647 drug administration Methods 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 206010047139 Vasoconstriction Diseases 0.000 description 7
- 230000008859 change Effects 0.000 description 7
- 238000003384 imaging method Methods 0.000 description 7
- 230000025033 vasoconstriction Effects 0.000 description 7
- 238000013459 approach Methods 0.000 description 6
- 210000004204 blood vessel Anatomy 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 230000002638 denervation Effects 0.000 description 6
- 230000002792 vascular Effects 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 238000002059 diagnostic imaging Methods 0.000 description 5
- 102000005962 receptors Human genes 0.000 description 5
- 108020003175 receptors Proteins 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 230000001747 exhibiting effect Effects 0.000 description 3
- 230000008035 nerve activity Effects 0.000 description 3
- 208000015658 resistant hypertension Diseases 0.000 description 3
- 210000002820 sympathetic nervous system Anatomy 0.000 description 3
- 230000036962 time dependent Effects 0.000 description 3
- 238000002604 ultrasonography Methods 0.000 description 3
- 101100412394 Drosophila melanogaster Reg-2 gene Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 229940124308 alpha-adrenoreceptor antagonist Drugs 0.000 description 2
- 239000002220 antihypertensive agent Substances 0.000 description 2
- 229940127088 antihypertensive drug Drugs 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 229960003624 creatine Drugs 0.000 description 2
- 239000006046 creatine Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 230000024924 glomerular filtration Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 230000036581 peripheral resistance Effects 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000036454 renin-angiotensin system Effects 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 238000001276 Kolmogorov–Smirnov test Methods 0.000 description 1
- 102000030619 alpha-1 Adrenergic Receptor Human genes 0.000 description 1
- 108020004102 alpha-1 Adrenergic Receptor Proteins 0.000 description 1
- 102000030484 alpha-2 Adrenergic Receptor Human genes 0.000 description 1
- 108020004101 alpha-2 Adrenergic Receptor Proteins 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 238000013528 artificial neural network Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008081 blood perfusion Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 230000003205 diastolic effect Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- 208000030613 peripheral artery disease Diseases 0.000 description 1
- 229960001999 phentolamine Drugs 0.000 description 1
- MRBDMNSDAVCSSF-UHFFFAOYSA-N phentolamine Chemical compound C1=CC(C)=CC=C1N(C=1C=C(O)C=CC=1)CC1=NCCN1 MRBDMNSDAVCSSF-UHFFFAOYSA-N 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000007674 radiofrequency ablation Methods 0.000 description 1
- 230000009103 reabsorption Effects 0.000 description 1
- 230000008664 renal activity Effects 0.000 description 1
- 230000008327 renal blood flow Effects 0.000 description 1
- 230000013878 renal filtration Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229960002312 tolazoline Drugs 0.000 description 1
- JIVZKJJQOZQXQB-UHFFFAOYSA-N tolazoline Chemical compound C=1C=CC=CC=1CC1=NCCN1 JIVZKJJQOZQXQB-UHFFFAOYSA-N 0.000 description 1
- 230000003639 vasoconstrictive effect Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/48—Diagnostic techniques
- A61B6/481—Diagnostic techniques involving the use of contrast agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/48—Diagnostic techniques
- A61B6/486—Diagnostic techniques involving generating temporal series of image data
- A61B6/487—Diagnostic techniques involving generating temporal series of image data involving fluoroscopy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/52—Devices using data or image processing specially adapted for radiation diagnosis
- A61B6/5211—Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data
- A61B6/5217—Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data extracting a diagnostic or physiological parameter from medical diagnostic data
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/36—Image-producing devices or illumination devices not otherwise provided for
- A61B90/37—Surgical systems with images on a monitor during operation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00434—Neural system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00505—Urinary tract
- A61B2018/00511—Kidney
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
- A61B2018/00577—Ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/0066—Sensing and controlling the application of energy without feedback, i.e. open loop control
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00666—Sensing and controlling the application of energy using a threshold value
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00863—Fluid flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/1815—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using microwaves
- A61B2018/1861—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using microwaves with an instrument inserted into a body lumen or cavity, e.g. a catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/36—Image-producing devices or illumination devices not otherwise provided for
- A61B90/37—Surgical systems with images on a monitor during operation
- A61B2090/376—Surgical systems with images on a monitor during operation using X-rays, e.g. fluoroscopy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/54—Control of apparatus or devices for radiation diagnosis
- A61B6/541—Control of apparatus or devices for radiation diagnosis involving acquisition triggered by a physiological signal
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physics & Mathematics (AREA)
- Radiology & Medical Imaging (AREA)
- Pathology (AREA)
- High Energy & Nuclear Physics (AREA)
- Optics & Photonics (AREA)
- Biophysics (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Physiology (AREA)
- Cardiology (AREA)
- Plasma & Fusion (AREA)
- Otolaryngology (AREA)
- Gynecology & Obstetrics (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Apparatus For Radiation Diagnosis (AREA)
- Surgical Instruments (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19202890.0A EP3808274A1 (en) | 2019-10-14 | 2019-10-14 | Renal denervation ablation monitoring using perfusion angiography |
| EP19202890.0 | 2019-10-14 | ||
| PCT/EP2020/077157 WO2021073862A1 (en) | 2019-10-14 | 2020-09-29 | Renal denervation ablation monitoring using perfusion angiography |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022551532A JP2022551532A (ja) | 2022-12-09 |
| JP2022551532A5 JP2022551532A5 (https=) | 2023-10-06 |
| JP7653981B2 true JP7653981B2 (ja) | 2025-03-31 |
Family
ID=68318782
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022521732A Active JP7653981B2 (ja) | 2019-10-14 | 2020-09-29 | 灌流血管造影を使用した腎除神経アブレーションのモニタリング |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US12171603B2 (https=) |
| EP (2) | EP3808274A1 (https=) |
| JP (1) | JP7653981B2 (https=) |
| CN (1) | CN114554993A (https=) |
| WO (1) | WO2021073862A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3756547A1 (en) * | 2019-06-28 | 2020-12-30 | Koninklijke Philips N.V. | Automated coronary angiography analysis |
| CN114052896A (zh) * | 2021-12-17 | 2022-02-18 | 苏州润迈德医疗科技有限公司 | 一种消融导管效果参数测评方法和测评装置 |
| DE102023206892A1 (de) * | 2023-07-20 | 2025-01-23 | Siemens Healthineers Ag | Mehrenergie-Röntgenbildgebung |
| WO2025082793A1 (en) * | 2023-10-20 | 2025-04-24 | Medtronic Ireland Manufacturing Unlimited Company | Intraprocedural guidance for renal denervation using vasoconstriction response to stimulation |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160095535A1 (en) | 2014-10-01 | 2016-04-07 | Medtronic Ardian Luxembourg S.a.r.I. | Systems and Methods for Evaluating Neuromodulation Therapy Via Hemodynamic Responses |
| US20160113699A1 (en) | 2013-05-23 | 2016-04-28 | CardioSonic Ltd. | Devices and methods for renal denervation and assessment thereof |
| JP2016513526A (ja) | 2013-03-11 | 2016-05-16 | タイラートン インターナショナル ホールディングス インコーポレイテッドＴｙｌｅｒｔｏｎ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｈｏｌｄｉｎｇｓ Ｉｎｃ． | 自律神経系モデリング及びその使用 |
| WO2017100140A2 (en) | 2015-12-08 | 2017-06-15 | Ablative Solutions, Inc. | Apparatus for effective ablation and nerve sensing associated with denervation |
| WO2018204284A1 (en) | 2017-05-04 | 2018-11-08 | Gynesonics Inc. | Methods for monitoring ablation progress with doppler ultrasound |
| WO2018229579A1 (en) | 2017-06-16 | 2018-12-20 | Biosense Webster (Israel) Ltd. | Renal ablation and visualization system and method with composite anatomical display image |
| WO2019147434A1 (en) | 2018-01-24 | 2019-08-01 | Medtronic Ardian Luxembourg S.A.R.L. | Denervation therapy |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2706939A4 (en) * | 2011-05-09 | 2015-05-27 | Cyberheart Inc | DEVICE, SYSTEM AND METHOD FOR RENOVASCULAR TREATMENT FOR RADIOSURGICAL RELIEF HYPERTENSION |
| US20130116496A1 (en) * | 2011-11-04 | 2013-05-09 | Ron Waksman | Apparatus and method for radiation treatment of a desired area in the renal vascular system of a patient |
| US10231778B2 (en) * | 2014-10-20 | 2019-03-19 | Biosense Webster (Israel) Ltd. | Methods for contemporaneous assessment of renal denervation |
-
2019
- 2019-10-14 EP EP19202890.0A patent/EP3808274A1/en not_active Withdrawn
-
2020
- 2020-09-29 JP JP2022521732A patent/JP7653981B2/ja active Active
- 2020-09-29 WO PCT/EP2020/077157 patent/WO2021073862A1/en not_active Ceased
- 2020-09-29 US US17/768,099 patent/US12171603B2/en active Active
- 2020-09-29 CN CN202080072270.7A patent/CN114554993A/zh active Pending
- 2020-09-29 EP EP20776186.7A patent/EP4044927A1/en active Pending
-
2024
- 2024-12-20 US US18/989,762 patent/US20250120662A1/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016513526A (ja) | 2013-03-11 | 2016-05-16 | タイラートン インターナショナル ホールディングス インコーポレイテッドＴｙｌｅｒｔｏｎ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｈｏｌｄｉｎｇｓ Ｉｎｃ． | 自律神経系モデリング及びその使用 |
| US20160113699A1 (en) | 2013-05-23 | 2016-04-28 | CardioSonic Ltd. | Devices and methods for renal denervation and assessment thereof |
| US20160095535A1 (en) | 2014-10-01 | 2016-04-07 | Medtronic Ardian Luxembourg S.a.r.I. | Systems and Methods for Evaluating Neuromodulation Therapy Via Hemodynamic Responses |
| WO2017100140A2 (en) | 2015-12-08 | 2017-06-15 | Ablative Solutions, Inc. | Apparatus for effective ablation and nerve sensing associated with denervation |
| WO2018204284A1 (en) | 2017-05-04 | 2018-11-08 | Gynesonics Inc. | Methods for monitoring ablation progress with doppler ultrasound |
| WO2018229579A1 (en) | 2017-06-16 | 2018-12-20 | Biosense Webster (Israel) Ltd. | Renal ablation and visualization system and method with composite anatomical display image |
| WO2019147434A1 (en) | 2018-01-24 | 2019-08-01 | Medtronic Ardian Luxembourg S.A.R.L. | Denervation therapy |
Also Published As
| Publication number | Publication date |
|---|---|
| CN114554993A (zh) | 2022-05-27 |
| JP2022551532A (ja) | 2022-12-09 |
| EP3808274A1 (en) | 2021-04-21 |
| US20250120662A1 (en) | 2025-04-17 |
| US12171603B2 (en) | 2024-12-24 |
| US20240081758A1 (en) | 2024-03-14 |
| EP4044927A1 (en) | 2022-08-24 |
| WO2021073862A1 (en) | 2021-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7653981B2 (ja) | 灌流血管造影を使用した腎除神経アブレーションのモニタリング | |
| JP7416617B2 (ja) | 動脈の供給能力と終末器官の必要量とを比較することにより心血管疾患の診断及び評価をするためのシステム及び方法 | |
| CN106102583B (zh) | 瘢痕和纤维心脏区的检测 | |
| JP7229170B2 (ja) | Ｅｃｇ信号からの心筋微小血管抵抗の推定に基づく冠状動脈疾患メトリック | |
| US20230233135A1 (en) | Sympathetic nervous system response to stimulation of carotid bodies for patient stratification in renal denervation | |
| CN112955974B (zh) | 用于确定肾脏去神经支配处置反应指数的设备、系统和方法 | |
| KR20170133391A (ko) | 생리학적 특성, 해부학적 특성, 및 환자 특성으로부터 관류 결핍을 예측하기 위한 시스템 및 방법 | |
| US20190200884A1 (en) | Devices and methods for stratification of patients for renal denervation based on intravascular pressure and wall thickness measurements | |
| US20230233251A1 (en) | Sympathetic nervous system response to blood flow alterations in renal vasculature for patient stratification in renal denervation | |
| US11284836B2 (en) | Methods and systems for improved prediction of fluid responsiveness | |
| WO2019243218A1 (en) | System and method for determining pulse wave velocity of vessels | |
| EP3686898A1 (en) | Determination of a treatment response index | |
| CA3000814A1 (en) | Blood volume assessment using high frequency ultrasound | |
| EP4681646A1 (en) | Evaluating blood vessel properties | |
| KR102792798B1 (ko) | 자율신경계 기능 검사 방법 및 장치 | |
| EP4681651A1 (en) | Renal denervation treatment guidance using hemodynamic co-registration and associated systems, devices, methods | |
| WO2025071916A1 (en) | Coronary vasoreactivity determination using coronary stimulator and a computer vision system | |
| WO2025190981A1 (en) | Renal denervation treatment guidance using hemodynamic co-registration and associated systems, devices, methods | |
| CN121483615A (zh) | 一种面向颈动脉狭窄人群nvc功能的动态评估方法、设备、介质和程序产品 | |
| WO2025172950A1 (en) | Methods and systems for predicting treatment outcomes, patient selection and personalized denervation therapy | |
| CN120284294A (zh) | 模拟心肌血流量的方法、装置及设备 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230928 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230928 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20240430 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240520 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20240815 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20241112 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20250221 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20250318 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7653981 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |